KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBIT: 2009-2024

Historic EBIT for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $61.4 million.

  • Incyte's EBIT rose 203.60% to $443.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2899.92%. This contributed to the annual value of $61.4 million for FY2024, which is 90.11% down from last year.
  • Latest data reveals that Incyte reported EBIT of $61.4 million as of FY2024, which was down 90.11% from $620.5 million recorded in FY2023.
  • In the past 5 years, Incyte's EBIT registered a high of $620.5 million during FY2023, and its lowest value of -$263.7 million during FY2020.
  • In the last 3 years, Incyte's EBIT had a median value of $579.4 million in 2022 and averaged $420.4 million.
  • In the last 5 years, Incyte's EBIT plummeted by 165.59% in 2020 and then soared by 322.16% in 2021.
  • Yearly analysis of 5 years shows Incyte's EBIT stood at -$263.7 million in 2020, then surged by 322.16% to $585.8 million in 2021, then fell by 1.08% to $579.4 million in 2022, then rose by 7.09% to $620.5 million in 2023, then plummeted by 90.11% to $61.4 million in 2024.